Tet2 mutations are also common in both T-cell and B-cell lymphomas, with a 40–70% incidence observed among patients with peripheral T-cell lymphoma (PTCL), particularly in subsets of angioimmunoblastic T-cell lymphoma (AITL)21. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.